TRVI
$12.83+7.82%
Trevi Therapeutics Inc.Stock · HealthcareRussell 2000 · 0.06% of IWMNasdaq Composite · 0.005% of ONEQUS Stock Market · 0.003% of VTIRussell 3000 · 0.002% of IWV
TRVI financial statements
The full income statement, balance sheet, and cash-flow statement for Trevi Therapeutics Inc. (TRVI), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
2024-06 72.6M2024-09 76.9M2024-12 96.7M2025-03 101.7M2025-06 121.8M2025-09 128.2M2025-12 128.4M2026-03 142.0M2026-06 142.5M+96.3% over 8 periods
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
PeriodRangeOrderChangeFiguresAs-reported fiscal years.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 49.3M-4.3% | 51.5M+51.9% | 33.9M+13.4% | 29.9M-7.9% | 32.5M-0.0% | ||
| Research & development | 33.5M-15.0% | 39.4M+66.3% | 23.7M+19.4% | 19.8M-13.7% | 23.0M+2.9% | |
| Selling, general & administrative | 15.8M+30.5% | 12.1M+18.6% | 10.2M+1.7% | 10.1M+6.1% | 9.49M-6.6% | |
| General & administrative | 15.8M+30.5% | 12.1M+18.6% | 10.2M+1.7% | 10.1M+6.1% | 9.49M-6.6% | |
| Operating income | -49.3M+4.3% | -51.5M-51.9% | -33.9M-13.4% | -29.9M+7.9% | -32.5M+0.0% | |
| Interest expense | 0.00-100.0% | 4.00K-99.0% | 391K-66.4% | 1.16M-3.2% | 1.20M+163.6% | |
| Interest & investment income | 6.54M+81.5% | 3.60M-24.1% | 4.75M | — | — | |
| Other non-operating income | -31.0K-106.7% | -15.0K-103.2% | 469K+62.3% | 289K+177.1% | -375K-30.7% | |
| Pre-tax income | -42.8M+10.7% | -47.9M-64.8% | -29.1M+0.3% | -29.2M+14.1% | -34.0M-3.6% | |
| Income tax | -64.0K-113.3% | -30.0K+6.3% | -32.0K+11.1% | -36.0K-71.4% | -21.0K-16.7% | |
| Net income | -42.8M+10.8% | -47.9M-64.8% | -29.1M+0.3% | -29.2M+14.1% | -33.9M-3.6% | |
| -$0.32+31.9% | -$0.47-62.1% | -$0.29+35.6% | -$0.45+69.8% | -$1.49 | ||
| EPS (basic) | -$0.32+31.9% | -$0.47-62.1% | -$0.29+35.6% | -$0.45+69.8% | -$1.49 | |
| Weighted-avg shares (basic) | 135M+32.1% | 102M+3.0% | 99.0M+53.4% | 64.5M+182.6% | 22.8M | |
| Weighted-avg shares (diluted) | 135M+32.1% | 102M+3.0% | 99.0M+53.4% | 64.5M+182.6% | 22.8M | |
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| 192M+75.1% | 109M+25.0% | 87.5M-28.6% | 123M+223.0% | 38.0M-18.0% | ||
| Cash & equivalents | 18.9M-44.5% | 34.1M+5.2% | 32.4M+157.3% | 12.6M-65.8% | 36.8M-18.2% | |
| Short-term investments | 169M+130.3% | 73.5M+45.4% | 50.6M-53.1% | 108M | — | |
| Prepaid expenses | 1.26M+34.5% | 939K-74.1% | 3.62M+355.5% | 795K-10.3% | 886K-30.1% | |
| Other current assets | 2.13M+146.0% | 867K-9.2% | 955K-27.2% | 1.31M+444.0% | 241K-9.1% | |
| 193M+74.4% | 111M+24.0% | 89.4M-27.3% | 123M+219.7% | 38.5M-18.4% | ||
| Property, plant & equipment | 178K+13.4% | 157K-27.3% | 216K+27.1% | 170K+220.8% | 53.0K-48.5% | |
| Operating lease right-of-use | 677K-26.0% | 915K-19.5% | 1.14M+4637.5% | 24.0K-81.7% | 131K-42.3% | |
| Other non-current assets | 928K+281.9% | 243K-18.2% | 297K+44.9% | 205K-38.6% | 334K-37.2% | |
| 9.75M-7.2% | 10.5M+80.4% | 5.82M-56.5% | 13.4M+5.3% | 12.7M+129.1% | ||
| Accounts payable | 3.91M+14.6% | 3.41M+88.7% | 1.81M-36.7% | 2.86M+0.3% | 2.85M+41.3% | |
| Accrued liabilities | 5.53M-18.8% | 6.81M+83.6% | 3.71M+5.4% | 3.52M-7.6% | 3.81M+11.2% | |
| Current lease liability | 307K+20.9% | 254K+38.0% | 184K+636.0% | 25.0K-79.2% | 120K+6.2% | |
| Finance lease liability (current) | 0.00-100.0% | 31.0K-74.6% | 122K | — | — | |
| 10.2M-9.4% | 11.3M+64.2% | 6.86M-55.9% | 15.6M-27.3% | 21.4M+7.8% | ||
| Non-current lease liability | 446K-40.3% | 747K-25.4% | 1.00M+49950.0% | 2.00K-91.7% | 24.0K-83.3% | |
| Operating lease liability (total) | 753K-24.8% | 1.00M-15.5% | 1.19M+4288.9% | 27.0K-81.3% | 144K-44.0% | |
| Finance lease liability (total) | — | 31.0K-79.7% | 153K | — | — | |
| Finance lease liability | — | — | 31.0K | — | — | |
| Other non-current liabilities | — | — | — | 3.00K | — | |
| 183M+83.9% | 99.6M+20.7% | 82.5M-23.2% | 107M+529.3% | 17.1M-37.4% | ||
| Common stock | 128K+36.2% | 94.0K+38.2% | 68.0K+13.3% | 60.0K+106.9% | 29.0K+52.6% | |
| Additional paid-in capital | 513M+32.7% | 387M+20.2% | 322M+1.3% | 318M+60.4% | 198M+13.6% | |
| Retained earnings | -330M-14.9% | -287M-20.0% | -239M-13.8% | -210M-16.1% | -181M-23.1% | |
| Accumulated other comprehensive income | 148K+142.6% | 61.0K+310.3% | -29.0K+76.2% | -122K | — | |
| Total liabilities & equity | 193M+74.4% | 111M+24.0% | 89.4M-27.3% | 123M+219.7% | 38.5M-18.4% | |
| Common shares issued | 128M+37.1% | 93.6M+37.1% | 68.3M+13.9% | 59.9M+110.3% | 28.5M+53.7% | |
| Common shares outstanding | 128M+37.1% | 93.6M+37.1% | 68.3M+13.9% | 59.9M+110.3% | 28.5M+53.7% | |
| Shares outstanding (cover) | 128M+32.8% | 96.7M+40.2% | 69.0M+14.8% | 60.0M+94.9% | 30.8M+54.7% | |
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| -42.1M-10.0% | -38.3M-20.6% | -31.7M-12.5% | -28.2M+2.7% | -28.9M+0.2% | ||
| Depreciation & amortization | 144K-2.0% | 147K+19.5% | 123K+186.0% | 43.0K-14.0% | 50.0K+6.4% | |
| Share-based compensation | 5.18M+44.5% | 3.59M+59.7% | 2.25M-3.4% | 2.33M-8.5% | 2.54M+5.2% | |
| Change in payables | -598K-137.3% | 1.60M+253.0% | -1.05M-11755.6% | 9.00K-98.9% | 831K+99.3% | |
| -94.1M-337.1% | -21.5M-136.2% | 59.4M+155.3% | -107M | — | ||
| Capital expenditure | 12.0K-65.7% | 35.0K-74.5% | 137K-13.8% | 159K | — | |
| Free cash flow | -42.1M-10.0% | -38.3M-20.2% | -31.8M-12.4% | -28.3M | — | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales/maturities of investments | 76.6M-0.5% | 77.0M+10.8% | 69.5M+265.8% | 19.0M | — | |
| 121M+96.8% | 61.5M+877.3% | -7.91M-107.1% | 111M+435.8% | 20.8M+24.3% | ||
| Long-term debt issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | |
| Long-term debt repaid | 0.00 | 0.00 | 0.00-100.0% | 5.83M | 0.00 | |
| Common stock issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common stock repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net change in cash | -15.2M-993.1% | 1.70M-91.4% | 19.8M+181.7% | -24.2M-196.7% | -8.17M+33.6% | |
| Interest paid | — | 4.00K-98.8% | 331K-44.3% | 594K-1.5% | 603K+235.0% | |
| Income taxes paid | -33.0K-3.1% | -32.0K | — | — | — | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 1.61B+303.6% | 398M+365.5% | 85.6M-26.0% | 116M+380.1% | 24.1M-50.0% | |
| P/B | 8.8×+119.5% | 4.0×+318.6% | 1.0×-9.3% | 1.1×-25.4% | 1.4×-20.1% | |
| Source filing | 10-K | 10-K | 10-K | 10-K | 10-K |
About this data
Source: TRVI’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TRVI filings on SEC EDGAR → Not investment advice.